Introduction/Overview Salmeterol xinafoate represents a cornerstone in the maintenance therapy of obstructive airway diseases, specifically asthma and chronic obstructive pulmonary disease (COPD). As a long-acting beta2-adrenoceptor agonist (LABA), it provides sustained bronchodilation, contrasting sharply with the rapid onset and short duration of its predecessor, salbutamol. The clinical introduction of salmeterol marked a significant advancement, enabling … Read more

Introduction/Overview Misoprostol is a synthetic prostaglandin E1 (PGE1) analog with a diverse and critical profile of therapeutic applications. Initially developed for the prevention of gastric mucosal injury associated with nonsteroidal anti-inflammatory drug (NSAID) therapy, its pharmacological actions on smooth muscle and the uterine cervix have led to its widespread use in obstetrics and gynecology. The … Read more

1. Introduction/Overview Sumatriptan represents a cornerstone in the acute pharmacological management of migraine and cluster headache disorders. As the first agent developed in the triptan class, its introduction in the early 1990s marked a significant advancement in headache therapeutics, providing a mechanism-specific treatment option superior to preceding non-specific analgesics. The clinical importance of sumatriptan is … Read more

Introduction/Overview Pentazocine is a synthetically derived opioid analgesic with a distinctive pharmacological profile, classified as an opioid agonist-antagonist. First synthesized in the 1960s, it was developed in an effort to create an analgesic with potent pain-relieving properties but a reduced potential for abuse and respiratory depression compared to pure μ-opioid receptor agonists like morphine. Its … Read more

Introduction/Overview Buprenorphine represents a cornerstone agent in the management of opioid use disorder and chronic pain, distinguished by its unique pharmacodynamic profile as a partial agonist at the mu-opioid receptor. Its development marked a significant advancement in opioid pharmacology, offering a therapeutic option with a ceiling effect on respiratory depression, which enhances its safety profile … Read more

Introduction/Overview Mefenamic acid is a non-steroidal anti-inflammatory drug (NSAID) belonging to the fenamate class, which has been utilized in clinical practice for several decades. It is distinguished from other NSAIDs by its specific chemical structure and certain pharmacodynamic properties. The drug serves as a prototype for understanding the pharmacology of anthranilic acid derivatives and continues … Read more

Introduction/Overview Ketorolac tromethamine represents a significant agent within the nonsteroidal anti-inflammatory drug (NSAID) class, distinguished primarily by its potent analgesic properties. Developed in the 1970s and approved for clinical use in the United States in 1989, it occupies a unique therapeutic niche as the first injectable NSAID approved for systemic use in the management of … Read more

Introduction/Overview Naproxen is a prototypical nonsteroidal anti-inflammatory drug (NSAID) with extensive clinical application in the management of pain, inflammation, and fever. As a member of the arylpropionic acid derivative class, it occupies a significant position in therapeutic regimens due to its well-established efficacy, over-the-counter availability in lower doses, and prescription strength for more severe conditions. … Read more